To establish medically useful guidelines for analytic precision of commonly used clinical laboratory procedures, the authors conducted a mail survey of-physicians selected randomly from national lists of specialists. They were asked to review, briefly, outlined clinical problems and select the change in test results that would alter their diagnosis or treatment or prompt further assessment of the patient's condition. The responses were used to calculate goals for laboratory precision that are sufficient to meet the present requirements of the average physician. The medically useful limits were compared with existing performance of laboratories as reported in national proficiency surveys and regional quality control programs. Almost all the common laboratory procedures they studied are being assayed at a precision level adequate for the perceived needs. The authors suggest that, for the more common constituents, further progress in clinical laboratory testing will depend on factors other than the improvement of analytic precision. (Key words: Medical usefulness of laboratory tests; Goals for analytic precision; Decision-making; Quality control) Am J Clin Pathol 1985; 83: [200] [201] [202] [203] [204] [205] BILLIONS OF LABORATORY TESTS are ordered annually in the United States, reflecting the physicians' reliance on analytic data to help diagnose disease and monitor the clinical progress of patients. Test results are not applied in a vacuum, of course. Multiple factors influence any particular test result, including physiologic changes, within-patient and between-patient variation, and laboratory precision. Physicians may not know exactly how much these factors affect test results, but they have learned by experience to ignore small changes. The question addressed here is what degree of precision does the clinician use in laboratory testing to provide adequate patient care.
The analytic quality of the laboratory assay has been well documented. Clinical pathologists know the degree of precision currently achieved in clinical laboratories from data gathered through national surveys and quality control programs. 6 ' 7 These also show that test precision has improved steadily. 7 Further advances will be achieved, but among clinical pathologists there is the concern that such efforts may be meaningless. If the physician reacts only when a patient's serum glucose increases from 100 to 130 mg/dL, efforts to achieve testing precision within 2% will not improve the diagnostic value of the test.
Setting goals for laboratory precision based on medical usefulness, that is, the precision needed for patient care, makes good sense. Another approach to setting laboratory precision requirements relies on the intraindividual variability, i.e., the change that can be observed in a single healthy individual over a period of time.
1 " 3 However, there is no evidence that limits based on biologic variation give data that are useful in medical practice. Very minor ailments or slight physiologic disturbances can change test results substantially without generating useful medical information.
In a pilot study of the medical usefulness criterion for laboratory precision, one of us (L.P.S.) measured the reaction of physicians to changes in test results through a questionnaire distributed to those in clinical practice. 8 The present study used the same type of questionnaire but surveyed a national sample of physicians. We set out to determine whether the precision currently achieved in hospital laboratories meets medical needs by comparing the physicians' opinions of what constitutes a significant change with precision data from the College of American Pathologists (CAP) quality control programs. We used the data to propose a set of medically useful criteria for laboratory testing.
Methods

Questionnaire Design
Questionnaires were sent to members of the American Medical Association. A computerized file was sampled randomly to provide the names of physicians specializing in pediatrics, family practice, hematology and pathology, and internal medicine.
The questionnaires consisted of six to nine vignettes describing a patient's condition and an initial test result.
These vignettes simulated three groups of clinical settings. Group 1 described healthy asymptomatic patients undergoing routine screening tests. Group 2 consisted of patients suffering from a variety of disorders: bleeding peptic ulcer, bleeding esophageal varices, renal failure, hepatitis, hemolytic disease of the newborn, cirrhosis, and tetany. Group 3 patients were being monitored to detect drug toxicity during the treatment of rheumatoid arthritis, tuberculosis, convulsive disorders, acute granulocytic leukemia, testicular carcinoma, or to determine the effect of treatment with Coumadin, diuretics, digoxin, fluids, and electrolytes.
The physicians surveyed were asked to indicate the smallest change in a test result at or beyond which they would take action such as ordering more tests, changing therapy, or considering another diagnosis. They received these questions: The first question was sent to internists, the second to physicians in family practice, hematology, internal medicine, and pathology. The same format was used for the remaining questions. The numeric selection list has been omitted. for calcium assay in your laboratory is 8. 
Derivation of the Medically Useful Coefficient of Variation
For each response the difference between the initial test result and the value selected as indicative of significant change was computed for all respondents and summarized. The 50th percentile was chosen as the reference point. In question 1, the upper limit of the reference range was used for calculation of significant change; the 50th percentile change was 13 U/L (30-43 U/L). In question 2, the significant change value selected by the 50th percentile was 1.2, which corresponds to a hemoglobin value of 12.8 g/dL.
Since laboratory precision commonly is expressed as the coefficient of variation (CV), the values indicated as significant changes were converted to a medically useful CV. Two methods were used, depending on the situation presented in the vignette.
In question 1, the physician compares a laboratory test value with an established value, in this case the upper end of the reference range. The reference value, R, is not subject to measurement error. The change, C, is computed as C = X -R, where X is the value selected by the physician as an indicator of significant change.
This change, C, is converted to the required standard deviation (S) required in testing by the formula:
The number 1.645 corresponds to the 95th percentile in a one-sided standard Gaussian curve. The formula comes from a test of the null hypothesis that there is no true change in the patient (X = R). The hypothesis is accepted if the Z statistic, (X -R)/S is less than 1.645. The requirement that S be less than C/1.645 gives only a 5% probability that the observed change is due solely to analytic variability.
CV is calculated by the formula: CV = (S/R) X 100
As an illustration, a physician who selects an aspartate aminotransferase of 43 U/L to indicate a significant change requires a laboratory capable of testing with a precision of: 
Estimates of Clinical Laboratory Precision
Data on the precision currently achieved in clinical laboratories are based on studies by Ross and associates 7 and Lohff and associates. 6 They estimated the long-term intralaboratory precision of more than 1,400 laboratories participating in the CAP Quality Assurance Program. Using their data, we compared the CV reported by the 50th percentile ranking of laboratories who perform analyses by automated technics with the medically useful CV. The percentage of laboratories in the CAP program with a CV within the limits of the medically useful CV was calculated to express the current state of the art of laboratory testing.
Results
A total of 745 questionnaires, 19% of those mailed, were returned for evaluation. Those included 124 family practitioners, 83 surgeons, 116 hematologists, 203 internists, 86 pediatricians, and 133 pathologists. Two of five physicians had practiced medicine for 10 years or less. Table 1 shows the 50th percentile response from physicians. There were differences in the application of test results in the three groups of patients. In the setting of a routine examination, physicians selected an increase in direct bilirubin from 0.3 to 0.6 mg/dL to signal a change in liver function; for a patient receiving chemotherapy, a change from 0.2 to 0.8 mg/dL was reported as significant. For a patient receiving diuretics, a change in potassium from 4.0 to 3.5 mEq/L was meaningful; for an asymptomatic patient, physicians chose a decrease from 4.0 to 3.2 mEq/L as significant. The selection of changes in calcium and thyroxine levels also varied with the clinical setting.
The responses were examined by the type of medical practice. In response to a question of cholesterol levels in an asymptomatic patient, internists regarded a change 204 from 210 to 280 mg/dL as significant, while all others chose an increase from 210 to 270 mg/dL. In a patient receiving chemotherapy for testicular cancer with an initial leukocyte count of 4,000/mm 3 , hematologists viewed a decrease of 800 cells as significant, while pathologists would respond to a decrease of 1,000, family practitioners, 1,150, internists, 1,120. For the other clinical situations, the 50th percentile of responses were nearly identical. Table 2 compares the CV required for clinical application with the current level of precision in laboratory testing. For every constituent included in the study, the medically useful CV encompasses the CV of testing. The differences are twofold of greater for AST, bilirubin, calcium, cholesterol, creatinine, glucose, iron, phosphate, potassium, total protein, triglycerides, and urea nitrogen, hematocrit, hemoglobin, leukocyte count, and prothrombin time.
A high proportion of laboratories in the CAP program achieved the medically useful limits of precision (Table  2) . Seventy-five percent perform within the medically derived CV of 28.7% for direct bilirubin assays at the 1 mg/dL level, and 87.3% have a CV less than 1.7% for sodium. For the remaining tests, 96-100% of laboratories satisfy the requirements indicated by the study.
Discussion
Three major findings emerge from the survey. First, the majority of physicians responding generally require a substantial change in test results before they alter diagnoses or treatment. Current laboratory precision falls well within these limits.
Second, physicians respond to the question of what constitutes a significant change in test values based to some degree on the clinical setting. In asymptomatic patients, the change required to create physician concern LIMIT FOR PRECISION 2 0 5 vol. 83-No. 2 MEDICALLY USEFUL was occasionally greater than in patients with acute illness or in drug and therapeutic monitoring regimes. Finally, there were only minor differences in selection among physicians from different specialties. An evaluation of responses by type of practice will be reported in detail later.
Why are medically useful precision limits considerably greater than laboratory precision? The process underlying medical decision making has received attention recently, 4 but the relation to laboratory testing is not established entirely. Statland 9 proposes that physicians have established discrete cut-off points for laboratory tests. These limits serve to discriminate between disease and nondisease states and do not necessarily coincide with reference (normal) ranges. Data from this study offer support for this concept. Physicians selected thyroxine levels of 4 and 12 Mg/dL to signal possible thyroid disorders, and, for calcium, 7.6 and 10.6 mg/dL, represent levels for further evaluation of the patient. These findings suggest that physicians are aware of the existing precision of laboratory tests and the degree of change in test results varies with the clinical setting.
Several factors affect laboratory testing, including inherent biologic variation, preanalytic factors (position of the patient while collecting samples, diet, technic of collection, handling of samples prior to analysis), and analytic variability. Add to these the consideration given by the physician for the sensitivity, specificity, and predictive value of a test. The physician probably weighs all of these variables in his evaluation of a test result. Support of this view comes from the study of Link and associates, 5 who investigated the response of physicians to elevated calcium levels. Minor alterations frequently were ignored apparently because of the physician's reluctance to pursue nonproductive studies. They conclude that physicians make complex clinical judgments when applying test results based on the degree of abnormality, the likelihood that further investigation will affect the therapy, and the cost associated with further investigation.
This study attempted to relate the value of test results to clinical problems using physicians' opinions as the data base. We believe that this approach is practical, simple, and reliable because it links test results to the clinical setting.
We propose that the medically useful CVs shown in Table 3 serve as a guide to laboratories in establishing analytic goals of performance. When the average laboratory achieves the precision in testing that exceeds the medically useful limits by several fold, additional efforts to improve performance probably will not increase diagnostic usefulness. The resources of the laboratory might be better directed to the study and control of preanalytic factors affecting a test and to the development of more appropriate tests for diagnosis and treatment. We do not mean to infer that laboratories should abandon the current practices of quality control, but the medically useful criteria for laboratory precision assist in placing laboratory precision and test utilization in the proper perspective.
